Date: Ongoing 3 month cycle, roughly August through October 2022.
Time: To be arranged between groups
Who is this event intended for? Members of PSI
What is the benefit of attending? Participants will have the opportunity to; Network with colleagues from the industry; Discuss and practice learnings from a wide range of books; and (if participating as a facilitator), an opportunity to lead and chair discussions.
PSI are running a book club! We will be reading and discussing non-technical books which are relevant to our roles. Participants will be split into smaller discussion groups so members can network with each other and practice exercises to help implement their learnings.
Please note: Once allocated, groups will liaise and arrange their own preferred time to meet and discuss the book, whether that's online or in-person. No meetings will set up by PSI.
The next book we are reading is "Never Split the Difference" by Chris Voss. This book is one of the most recommended books to start improving your negotiations skills. A former FBI hostage negotiator offers a new, field-tested approach to negotiating - exciting to read with effective methods for any situation.
We are also looking for facilitators who will be leading the discussion groups. Facilitators will be provided guidance on how to run the group discussions and there will be a Q&A session at the beginning for any questions that may arise. Make sure to indicate on the registration form if you are interested!
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This webinar will cover the history of cell/gene therapy, major regulatory advances, the role of quantitative scientists in drug development of these novel therapeutics, and discuss opportunities for innovation and product advancement.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
We have exciting new opportunities available for Study Statisticians, Support Statisticians and Exploratory Statisticians at various levels.
